Doxorubicin-sanguinarine nanoparticles: formulation and evaluation of breast cancer cell apoptosis and cell cycle

References

• Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer; 2020. [cited Feb 2021] https://gco.iarc.fr/today
   Google Scholar
• WHO. Cancer FsAfhwwin-rf-sdc.
   Google Scholar
• Basu P, Kumar GS. Sanguinarine and its role in chronic diseases. Adv Exp Med Biol. 2016;928:155–172. doi: 10.1007/978-3-319-41334-1_7.
   PubMed Web of Science ®Google Scholar
• Basu P, Kumar GS. Sanguinarine and its role in chronic diseases. In: Gupta SC, Prasad S, Aggarwal BB, editors. Advances in experimental medicine and biology: anti-inflammatory nutraceuticals and chronic diseases. Vol. 928. Cham: Springer International Publishing; 2016. pp. 155–172.
   Google Scholar
• Prescott M, Mitchell J, Totti S, et al. Sonodynamic therapy combined with novel anti-cancer agents, sanguinarine and ginger root extract: synergistic increase in toxicity in the presence of PANC-1 cells in vitro. Ultrason Sonochem. 2018;40(Pt B):72–80. doi: 10.1016/j.ultsonch.2017.05.018.
   PubMedGoogle Scholar
• Eid SY, El-Readi MZ, Wink M. Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells. Phytomedicine. 2012;19(14):1288–1297. doi: 10.1016/j.phymed.2012.08.010.
   PubMed Web of Science ®Google Scholar
• Jiang L, Wang X, Wang Y, et al. The synthesis and biological evaluation of sanguinarine derivatives as anti-non-small cell lung cancer agents. RSC Med Chem. 2020;11(2):293–296. doi: 10.1039/c9md00494g.
   PubMedGoogle Scholar
• Sarkhosh-Inanlou R, Molaparast M, Mohammadzadeh A, et al. Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin-resistant ovarian cancer (A2780) cells. Chem Biol Drug Des. 2020;95(2):215–223. doi: 10.1111/cbdd.13621.
   PubMed Web of Science ®Google Scholar
• Saeed MEM, Mahmoud N, Sugimoto Y, et al. Molecular determinants of sensitivity or resistance of cancer cells toward sanguinarine. Front Pharmacol. 2018;9:136. PMCPMC5834429. doi: 10.3389/fphar.2018.00136.
   PubMed Web of Science ®Google Scholar
• Wink M, Ashour ML, El-Readi MZ. Secondary metabolites from plants inhibiting ABC transporters and reversing resistance of cancer cells and microbes to cytotoxic and antimicrobial agents. Front Microbiol. 2012;3:130. doi: 10.3389/fmicb.2012.00130.
   PubMed Web of Science ®Google Scholar
• Eid SY, El-Readi MZ, Eldin EE, et al. Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and Colon cancer cells. Phytomedicine. 2013;21(1):47–61. doi: 10.1016/j.phymed.2013.07.019.
   PubMed Web of Science ®Google Scholar
• Eid SY, El-Readi MZ, Wink M. Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters. Phytomedicine. 2012;19(11):977–987. doi: 10.1016/j.phymed.2012.05.010.
   PubMed Web of Science ®Google Scholar
• Zeng L, Gowda BJ, Ahmed MG, et al. Advancements in nanoparticle-based treatment approaches for skin cancer therapy. Mol Cancer. 2023;22(1):10.
   PubMed Web of Science ®Google Scholar
• Dongsar TT, Dongsar TS, Abourehab MA, et al. Emerging application of magnetic nanoparticles for breast cancer therapy. Eur Polym J. 2023;187:111898. doi: 10.1016/j.eurpolymj.2023.111898.
   Web of Science ®Google Scholar
• Kesharwani P, Sheikh A, Abourehab MA, et al. A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy. J Drug Delivery Sci Technol. 2023;80:104164. doi: 10.1016/j.jddst.2023.104164.
   Web of Science ®Google Scholar
• Dawoud M, Abourehab MA, Abdou R. Monoolein cubic nanoparticles as novel carriers for docetaxel. J Drug Delivery Sci Technol. 2020;56:101501. doi: 10.1016/j.jddst.2020.101501.
   Web of Science ®Google Scholar
• Akkın S, Varan G, Bilensoy E. A review on cancer immunotherapy and applications of nanotechnology to chemoimmunotherapy of different cancers. Molecules. 2021;26(11):3382. doi: 10.3390/molecules26113382.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Ma R, Sang L. Gold nanoparticles and gold nanorods in the landscape of cancer therapy. Mol Cancer. 2023;22(1):98.
   PubMed Web of Science ®Google Scholar
• Hussain Z, Abourehab MA, Khan S, et al. Silver nanoparticles: a promising nanoplatform for targeted delivery of therapeutics and optimized therapeutic efficacy. In: Metal nanoparticles for drug delivery and diagnostic applications. Boston: Elsevier; 2020. p. 141–173.
   Google Scholar
• Sun Q, Li W, Li H, et al. Preparation, characterization and anti-ulcer efficacy of sanguinarine loaded solid lipid nanoparticles. Pharmacology. 2017;100(1-2):14–24. doi: 10.1159/000454882.
   PubMed Web of Science ®Google Scholar
• Gibbons SM, Jones E, Bearquiver A, et al. Human and environmental impacts on river sediment microbial communities. PLOS One. 2014;9(5):e97435–e97435. doi: 10.1371/journal.pone.0097435.
   PubMed Web of Science ®Google Scholar
• Kim IH, Park JH, Cheong IW, et al. Swelling and drug release behavior of tablets coated with aqueous hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles. J Control Release. 2003;89(2):225–233. doi: 10.1016/s0168-3659(03)00089-0.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH, Alhathloul SS, Aljohani ASM, et al. Green synthesis of silver nanoparticles incorporated aromatherapies utilized for their antioxidant and antimicrobial activities against some clinical bacterial isolates. Bioinorg Chem Appl. 2022;2022:2432758–2432714. doi: 10.1155/2022/2432758.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH, Tawfeek HM. Development and evaluation of fluorescent gold nanoparticles. Drug Dev Ind Pharm. 2018;44(10):1679–1684. doi: 10.1080/03639045.2018.1483400.
   PubMed Web of Science ®Google Scholar
• Imanparast F, Faramarzi MA, Paknejad M, et al. Preparation, optimization, and characterization of simvastatin nanoparticles by electrospraying: an artificial neural networks study. J Appl Polym Sci. 2016;133(28):4–11. doi: 10.1002/app.43602.
   Web of Science ®Google Scholar
• Abdellatif AAH, Alsharidah M, Al Rugaie O, et al. Silver nanoparticle-coated ethyl cellulose inhibits tumor necrosis factor-alpha of breast cancer cells. Drug Des Devel Ther. 2021;15:2035–2046. doi: 10.2147/DDDT.S310760.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH, Alturki HNH, Tawfeek HM. Different cellulosic polymers for synthesizing silver nanoparticles with antioxidant and antibacterial activities. Sci Rep. 2021;11(1):84. doi: 10.1038/s41598-020-79834-6.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH, Rasheed Z, Alhowail AH, et al. Silver citrate nanoparticles inhibit PMA-Induced TNFalpha expression via deactivation of NF-kappaB activity in human cancer cell-lines, MCF-7. Int J Nanomed. 2020;15:8479–8493. doi: 10.2147/IJN.S274098.
   PubMed Web of Science ®Google Scholar
• Tawfeek HM, Abdellatif AAH, Abdel-Aleem JA, et al. Transfersomal gel nanocarriers for enhancement the permeation of lornoxicam. J Drug Delivery Sci Technol. 2020;56:101540. doi: 10.1016/j.jddst.2020.101540.
   Web of Science ®Google Scholar
• Abdellatif AAH, Younis MA, Alsharidah M, et al. Biomedical applications of quantum dots: overview, challenges, and clinical potential. Int J Nanomed. 2022;17:1951–1970. doi: 10.2147/IJN.S357980.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH, Younis MA, Alsowinea AF, et al. Lipid nanoparticles technology in vaccines: shaping the future of prophylactic medicine. Colloids Surf B Biointerfaces. 2022;222:113111. doi: 10.1016/j.colsurfb.2022.113111.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH, Tolba NS, Alsharidah M, et al. PEG-4000 formed polymeric nanoparticles loaded with cetuximab downregulate p21 & stathmin-1 gene expression in cancer cell lines. Life Sci. 2022;300:120581. doi: 10.1016/j.lfs.2022.120403.
   PubMedGoogle Scholar
• Abdellatif AAH, Alawadh SH, Bouazzaoui A, et al. Anthocyanins rich pomegranate cream as a topical formulation with anti-aging activity. J Dermatolog Treat. 2021;32(8):983–990. doi: 10.1080/09546634.2020.1721418.
   PubMed Web of Science ®Google Scholar
• Aljohani ASM, Abdellatif AAH, Rasheed Z, et al. Gold-Nanoparticle-Conjugated citrate inhibits tumor necrosis factor-alpha expression via suppression of nuclear factor kappa B (NF-kappaB) activation in breast cancer cells. J Biomed Nanotechnol. 2022;18(2):581–588. doi: 10.1166/jbn.2022.3266.
   PubMed Web of Science ®Google Scholar
• Abdellatif AA, Tawfeek HM. Transfersomal nanoparticles for enhanced transdermal delivery of clindamycin. AAPS PharmSciTech. 2016;17(5):1067–1074. doi: 10.1208/s12249-015-0441-7.
   PubMed Web of Science ®Google Scholar
• Nour Eldin EEM, Nour Eldein MM, El-Readi MZ, et al. Evaluation of the diagnostic and predicative values of 8-Iso-Prostaglandin F2alpha as a biomarker of breast cancer. Oncol Res Treat. 2020;43(10):506–517. doi: 10.1159/000509671.
   PubMed Web of Science ®Google Scholar
• Nour Eldin EEM, El-Readi MZ, Nour Eldein MM, et al. 8-Hydroxy-2'-deoxyguanosine as a discriminatory biomarker for early detection of breast cancer. Clin Breast Cancer. 2019;19(2):e385–e393. doi: 10.1016/j.clbc.2018.12.013.
   PubMed Web of Science ®Google Scholar
• Eid SY, Althubiti MA, Abdallah ME, et al. The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic enzymes. Phytomedicine. 2020;77:153280. doi: 10.1016/j.phymed.2020.153280.
   PubMed Web of Science ®Google Scholar
• Abdallah ME, El-Readi MZ, Althubiti MA, et al. Tamoxifen and the PI3K inhibitor: LY294002 synergistically induce apoptosis and cell cycle arrest in breast cancer MCF-7 cells. Molecules. 2020;25(15):3355. doi: 10.3390/molecules25153355.
   PubMed Web of Science ®Google Scholar
• Abdalla AN, Di Stefano M, Poli G, et al. Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived compound contributes to the increase of the chemosensitivity of MCF7/ADR-Resistant cells to doxorubicin. Molecules. 2021;27(1):90. doi: 10.3390/molecules27010090.
   PubMed Web of Science ®Google Scholar
• Almaimani RA, Aslam A, Ahmad J, et al. In vivo and in vitro enhanced tumoricidal effects of metformin, active vitamin D3, and 5-fluorouracil triple therapy against colon cancer by modulating the PI3K/akt/PTEN/mTOR network. Cancers. 2022;14(6):1538. doi: 10.3390/cancers14061538.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH, Aldalaen SM, Faisal W, et al. Somatostatin receptors as a new active targeting sites for nanoparticles. Saudi Pharm J. 2018;26(7):1051–1059. doi: 10.1016/j.jsps.2018.05.014.
   PubMed Web of Science ®Google Scholar
• Abdellatif AA, Zayed G, El-Bakry A, et al. Novel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptors. Drug Dev Ind Pharm. 2016;42(11):1782–1791. doi: 10.3109/03639045.2016.1173052.
   PubMed Web of Science ®Google Scholar
• Deshmukh K, Ahamed MB, Deshmukh R, et al. Biopolymer composites with high dielectric performance: interface engineering. In: Sadasivuni KK, Cabibihan JJ, Ponnamma D, AlMaadeed MAA, Kim J, editors. Biopolymer composites in electronics. Oxford: Elsevier; 2017. pp. 27–128. doi: 10.1016/B978-0-12-809261-3.00003-6.
   Google Scholar
• El-Badry M, Fetih G, Fathy M. Improvement of solubility and dissolution rate of indomethacin by solid dispersions in gelucire 50/13 and PEG4000. Saudi Pharm J. 2009;17(3):217–225. doi: 10.1016/j.jsps.2009.08.006.
   PubMedGoogle Scholar
• Sabra R, Billa N, Roberts CJ. Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer. Int J Pharm. 2019;572:118775. doi: 10.1016/j.ijpharm.2019.118775.
   PubMed Web of Science ®Google Scholar
• Bhaskar V, Prakash R, Devanna N. Development, characterization and evaluation of simvastatin solid lipid nanoparticles loaded transdermal patch. J Chem Pharm Res. 2016;9(2):702–708.
   Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57. doi: 10.3390/pharmaceutics10020057.
   PubMed Web of Science ®Google Scholar
• Fissan H, Ristig S, Kaminski H, et al. Comparison of different characterization methods for nanoparticle dispersions before and after aerosolization. Anal Methods. 2014;6(18):7324. doi: 10.1039/C4AY01203H.
   Web of Science ®Google Scholar
• Zheng T, Bott S, Huo Q. Techniques for accurate sizing of gold nanoparticles using dynamic light scattering with particular application to chemical and biological sensing based on aggregate formation. ACS Appl Mater Interfaces. 2016;8(33):21585–21594. doi: 10.1021/acsami.6b06903.
   PubMed Web of Science ®Google Scholar
• Mock JJ, Barbic M, Smith DR, et al. Shape effects in plasmon resonance of individual colloidal silver nanoparticles. J Chem Phys. 2002;116(15):6755–6759. doi: 10.1063/1.1462610.
   Web of Science ®Google Scholar
• Steinigeweg D, Schlücker S. Monodispersity and size control in the synthesis of 20-100 nm quasi-spherical silver nanoparticles by citrate and ascorbic acid reduction in glycerol-water mixtures. Chem Commun. 2012;48(69):8682–8684. doi: 10.1039/c2cc33850e.
   PubMed Web of Science ®Google Scholar
• Ranneh A-H, Iwao Y, Noguchi S, et al. The use of surfactants to enhance the solubility and stability of the water-insoluble anticancer drug SN38 into liquid crystalline phase nanoparticles. Int J Pharm. 2016;515(1-2):501–505. doi: 10.1016/j.ijpharm.2016.10.058.
   PubMedGoogle Scholar
• Abdellatif AAH, Ibrahim MA, Amin MA, et al. Cetuximab conjugated with octreotide and entrapped calcium alginate-beads for targeting somatostatin receptors. Sci Rep. 2020;10(1):4736. doi: 10.1038/s41598-020-61605-y.
   PubMed Web of Science ®Google Scholar
• El-Say KM. Maximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using draper-lin small composite design. Drug Des Devel Ther. 2016;10:825–839. doi: 10.2147/DDDT.S101900.
   PubMed Web of Science ®Google Scholar
• Li D, Rosito G, Slagle T. Structure-activity relationship: analyses of P-glycoprotein substrates and inhibitors [research support, non-U.S. Gov’t review]. J Clin Pharm Ther. 2003;38(6):445–449.
   Google Scholar
• El-Readi MZ, Al-Abd AM, Althubiti MA, et al. Multiple molecular mechanisms to overcome multidrug resistance in cancer by natural secondary metabolites. Front Pharmacol. 2021;12:658513. doi: 10.3389/fphar.2021.658513.
   PubMed Web of Science ®Google Scholar
• Babich H, Zuckerbraun HL, Barber IB, et al. Cytotoxicity of sanguinarine chloride to cultured human cells from oral tissue. Pharmacol Toxicol. 1996;78(6):397–403. doi: 10.1111/j.1600-0773.1996.tb00225.x.
   PubMedGoogle Scholar
• Schmeller T, Latz-Brüning B, Wink M. Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores [research support, non-U.S. Gov’t]. Phytochemistry. 1997;44(2):257–266. doi: 10.1016/s0031-9422(96)00545-6.
   PubMed Web of Science ®Google Scholar
• Stiborová M, Simánek V, Frei E, et al. DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique. Chem Biol Interact. 2002;140(3):231–242. doi: 10.1016/s0009-2797(02)00038-8.
   PubMed Web of Science ®Google Scholar
• Ding ZH, Tang SC, Weerasinghe P, et al. The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. Biochem Pharmacol. 2002;63(8):1415–1421. doi: 10.1016/s0006-2952(02)00902-4.
   PubMed Web of Science ®Google Scholar
• Chaturvedi MM, Kumar A, Darnay BG, et al. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-κB activation, IκBα phosphorylation, and degradation. J Biol Chem. 1997;272(48):30129–30134. doi: 10.1074/jbc.272.48.30129.
   PubMed Web of Science ®Google Scholar
• Wolff J, Knipling L. Antimicrotubule properties of benzophenanthridine alkaloids. Biochemistry. 1993;32(48):13334–13339. doi: 10.1021/bi00211a047.
   PubMed Web of Science ®Google Scholar
• Lee JS, Jung WK, Jeong MH, et al. Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of bax/bcl-2 ratio and caspase-9-dependent pathway. Int J Toxicol. 2012;31(1):70–77. doi: 10.1177/1091581811423845.
   PubMed Web of Science ®Google Scholar
• Tsukamoto H, Kondo S, Mukudai Y, et al. Evaluation of anticancer activities of benzo[c]phenanthridine alkaloid sanguinarine in oral squamous cell carcinoma cell line [research support, non-U.S. Gov’t]. Anticancer Res. 2011;31(9):2841–2846.
   PubMed Web of Science ®Google Scholar
• Larsson DE, Wickström M, Hassan S, et al. The cytotoxic agents NSC-95397, brefeldin A, bortezomib and sanguinarine induce apoptosis in neuroendocrine tumors in vitro [research support, non-U.S. Gov’t]. Anticancer Res. 2010;30(1):149–156.
   PubMed Web of Science ®Google Scholar
• Vrba J, Dolezel P, Vicar J, et al. Cytotoxic activity of sanguinarine and dihydrosanguinarine in human promyelocytic leukemia HL-60 cells. Toxicol in Vitro. 2009;23(4):580–588. doi: 10.1016/j.tiv.2009.01.016.
   PubMed Web of Science ®Google Scholar
• Han MH, Yoo YH, Choi YH. Sanguinarine-induced apoptosis in human leukemia U937 cells via bcl-2 downregulation and caspase-3 activation. Chemotherapy. 2008;54(3):157–165. PubMed PMID: 18560221; eng. doi: 10.1159/000140359.
   PubMed Web of Science ®Google Scholar
• Halwani AA. Development of pharmaceutical nanomedicines: from the bench to the market. Pharmaceutics. 2022;14(1):106. doi: 10.3390/pharmaceutics14010106.
   PubMed Web of Science ®Google Scholar
• Hałas-Wiśniewska M, Zielińska W, Izdebska M, et al. The synergistic effect of piperlongumine and sanguinarine on the non-small lung cancer. Molecules. 2020;25(13):3045. doi: 10.3390/molecules25133045.
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang X, Deng J, et al. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma. Cancer Lett. 2019;459:50–58. doi: 10.1016/j.canlet.2019.05.042.
   PubMed Web of Science ®Google Scholar
• Malikova J, Zdarilova A, Hlobilkova A. Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006;150(1):5–12. doi: 10.5507/bp.2006.001.
   PubMedGoogle Scholar
• Malíková J, Zdařilová A, Hlobilková A, et al. The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine. Cell Biol Toxicol. 2006;22(6):439–453. doi: 10.1007/s10565-006-0109-x.
   PubMed Web of Science ®Google Scholar
• Adhami VM, Aziz MH, Reagan-Shaw SR, et al. Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol Cancer Ther. 2004;3(8):933–940.
   PubMed Web of Science ®Google Scholar